Semi-Annual Balance Sheet

KYORIN Pharmaceutical Co., Ltd. - Filing #7731582

Concept As at
2017-09-30
As at
2017-03-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
44,245,000,000 JPY
43,619,000,000 JPY
Securities
2,300,000,000 JPY
5,007,000,000 JPY
Other
3,753,000,000 JPY
4,976,000,000 JPY
Allowance for doubtful accounts
-35,000,000 JPY
-44,000,000 JPY
Current assets
117,333,000,000 JPY
126,267,000,000 JPY
Non-current assets
Property, plant and equipment
22,728,000,000 JPY
22,432,000,000 JPY
Property, plant and equipment
Intangible assets
Intangible assets
1,672,000,000 JPY
1,204,000,000 JPY
Investments and other assets
Investment securities
46,423,000,000 JPY
40,647,000,000 JPY
Investments and other assets
48,258,000,000 JPY
42,763,000,000 JPY
Other
1,648,000,000 JPY
1,690,000,000 JPY
Allowance for doubtful accounts
-65,000,000 JPY
-65,000,000 JPY
Non-current assets
72,659,000,000 JPY
66,400,000,000 JPY
Assets
189,993,000,000 JPY
192,668,000,000 JPY
Liabilities
Current liabilities
Short-term borrowings
872,000,000 JPY
1,321,000,000 JPY
Income taxes payable
618,000,000 JPY
1,194,000,000 JPY
Other
8,653,000,000 JPY
8,601,000,000 JPY
Current liabilities
22,835,000,000 JPY
25,033,000,000 JPY
Non-current liabilities
Non-current liabilities
9,656,000,000 JPY
9,797,000,000 JPY
Long-term borrowings
3,754,000,000 JPY
3,630,000,000 JPY
Other
1,996,000,000 JPY
2,407,000,000 JPY
Liabilities
32,492,000,000 JPY
34,831,000,000 JPY
Other liabilities
Provision for retirement benefits for directors (and other officers)
JPY
16,000,000 JPY
Provision for bonuses
2,454,000,000 JPY
2,690,000,000 JPY
Other liabilities
Net assets
Shareholders' equity
Share capital
700,000,000 JPY
700,000,000 JPY
Capital surplus
Capital surplus
4,752,000,000 JPY
4,752,000,000 JPY
Retained earnings
Retained earnings
148,702,000,000 JPY
150,301,000,000 JPY
Treasury shares
-2,846,000,000 JPY
-3,168,000,000 JPY
Shareholders' equity
151,308,000,000 JPY
152,585,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
8,318,000,000 JPY
7,645,000,000 JPY
Valuation and translation adjustments
6,192,000,000 JPY
5,251,000,000 JPY
Net assets
157,501,000,000 JPY
157,837,000,000 JPY
Liabilities and net assets
189,993,000,000 JPY
192,668,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.